Industry news

NASDAQ OMX and Moscow Exchange Launch Partnership to Promote the Russian Tech and Biotech Community

Rusnano

NASDAQ OMX (NDAQ) and Moscow Exchange (MOEX) today announced the signing of a  co-operation  agreement. Within this agreement both exchanges will work jointly in further developing the Russian technology and biotechnology community. The aim of the  co-operation  is to jointly facilitate access to capital for the fast growing Russian  start-up  community and to promote listings at both exchanges.

VC funding follows tepid pace in Q3 as first-time biotech rounds shrive

John Carroll, FierceBiotech

Biotech companies in the U.S. drew a weak $852 million in venture support over the past quarter, a distinct downturn over a burst of new financing rounds in the second quarter. That dollar figure represented a 39% plunge from the second quarter, though the smaller bankroll was divided among 123 deals, with a 10% jump in the number of companies involved.

Russia: pharma sales "to grow 11% this year"

Lynne Taylor, Pharma Times Online

Pharmaceutical sales in Russia are expected to reach $24.29 billion this year from $22.22 billion in 2012, which is up 9.3% in US dollars and 11% in local currency terms, says new research.

FierceMedicalDevices' 2013 Fierce 15

Mark Hollmer, FierceMedicalDevices

This year's crop endured the struggles many startups face and came out ahead. They've attracted substantial funding from major investors in a tough market, proving the worth of their products. Many are also already in--or close to--market with their signature products, a sign of stability that draws investor commitments much more these days than companies on the earlier side of development.

“Rusnano” established the managing company for itself

Venture News

The Board of directors of “Rosnano”, OJSC has approved a deal, foreseeing investment of 990K RUB in the charter capital of the established “Managing Company “Rosnano”, LLC. In future it will become private, and the idea of privatization of “Rosnano” recedes into the past. The Managing Company is established in accordance with approved in June, 2012 new strategy of “Rosnano”, the core of which is separation of management functions and assets owning.
 

Consumer Spending is Expected to Cool in Russia’s Pharmaceuticals & Healthcare Sector

PRWEB UK

Business Monitor examines key issues affecting the Pharmaceuticals and healthcare industry in Russia and provides short- and long-term forecasts for the sector.

Elsevier Contributes Scopus Data to Development of Russian Map of Science

PRNewsWire

Russian Ministry of Education has signed an agreement to include Scopus Custom Data in the development of a national research assessment tool Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that the Russian Ministry of Education and Science has signed an agreement to include Scopus Custom Data in a nation-wide research assessment tool: Russia's Map of Science.

Siberian scientists develop nanodrugs to fight cancer; regulators give green light

Marchmont Innovation News

Siberian researchers at Tomsk Polytechnic University’ Institute of High Technology Physics have developed what they call “nanodrugs” based on organic synthesis to fight various cancers, E-News  reported . 
 

Ophthalmologists urged Russians to check sight by means of the Internet

RF News From Russia

In the World Day of sight which is celebrated on October 10, ophthalmologists urged people not to forget about importance of prevention of a disease of eyes. As it is noted in the press release which has arrived in edition KM.RU, not all needing correction of sight address to experts. Data of the conducted researches showed that only 10 percent of Russians annually visit the ophthalmologist for survey. Now will be able to prove gravity of the intentions now to any Internet polzoval.

Indian companies leave footprints on Russian generic drug market

Alexandra Katz, Russia & India Report

Ranbaxy, India’s largest generic drug manufacturer announced the completion of 20 years in Russia. It is among many Indian players struggling against tough competition from European and domestic drug manufacturers in Russian emerging generic drugs market.